Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

PACS Group, Inc. (PACS) Institutional Ownership & Insider Trading

239 institutions reported holding PACS Group, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 80 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PACSPACS Group, Inc.Follow PACS — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
7.5B
P/E TTM
27.9
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

239 institutions held 31.3% of the shares. Across filers that reported both quarters, shares held changed +5.9%.

Increased+94New+44Decreased-53Closed-22

Largest moves, shares (millions)

American Century Companies+1.3MFMR+1.0MAmeriprise Financial+0.9MAlyeska Investment Group-1.5MCohen & Steers-0.8MCitadel Advisors-0.5M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Sep 24-2.8Dec 24-3.5Mar 25-0.1Jun 25-0.7Sep 25-0.4Dec 25+2.7Mar 26+2.7Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2623950+5.9%94445322
Mar 2621647+6.7%69604132
Dec 2518445-0.9%51436221
Sep 2515644-1.7%49254917
Jun 2514745-0.1%59323322
Mar 2514145-7.2%51194320
Dec 2414549-5.5%61382643
Sep 2414850—————

PACS Group, Inc. — questions

Who owns PACS Group, Inc. stock?
239 institutions reported PACS Group, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: COHEN & STEERS, INC. (5.3%), FMR LLC (3.9%), BlackRock, Inc. (2.6%).
Are PACS Group, Inc. insiders buying or selling?
80 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from PACS Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.